Wave Life Sciences, Inc.
corporate_fare Company Profile
Wave Life Sciences, Inc. (NASDAQ:WVE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for WVE at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Wave Life Sciences Files Annual Report, Details $497M Capital Raise, Pipeline Progress, and Executive Trading Plans
- Wave Life Sciences Confirms Strong Cash Runway and Advances Key Clinical Programs
- Wave Life Sciences Regains Full Rights to WVE-006, Plans Accelerated FDA Engagement for AATD Therapy
- Wave Life Sciences Unveils Robust 2026 Pipeline Strategy and Strong Cash Runway
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$42.73M
Net Income
-$204.38M
Diluted EPS
-$1.21
Op. Cash Flow
-$187.49M
Free Cash Flow
-$188.21M
Operating Income
-$215.38M
Cash & Equivalents
$602.07M
Debt / Equity
0.00×
Net Margin
-478.3%
Shares Outstanding
187.66M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197330
show_chartPrice Chart
Loading chart...
feed WVE - Filings & News (Page 2)
WVE
Feb 26, 2026, 7:50 AM EST
Price at Filing:
$14.50
Real-time Price:
$2.60
Change:
-$11.90 (-82%)
Market Cap:
$504.906M
WVE
Feb 26, 2026, 7:37 AM EST
Price at Filing:
$14.60
Real-time Price:
$2.60
Change:
-$12.00 (-82%)
Market Cap:
$504.906M
WVE
Feb 02, 2026, 7:41 AM EST
Wave Life Sciences Regains Full Rights to WVE-006, Plans Accelerated FDA Engagement for AATD Therapy
Price at Filing:
$12.76
Real-time Price:
$2.60
Change:
-$10.16 (-80%)
Market Cap:
$504.906M
WVE
Jan 12, 2026, 7:35 AM EST
Price at Filing:
$13.91
Real-time Price:
$2.60
Change:
-$11.31 (-81%)
Market Cap:
$504.906M